Inflammatory bowel disease (IBD) doesn’t have a single cause. It develops when a genetically susceptible person’s immune system begins attacking the lining of their digestive tract, typically triggered by some combination of environmental factors and shifts in gut bacteria. Researchers have identified over 240 genetic risk regions linked to the disease, but genes alone don’t explain it. IBD is rising sharply in urbanized and industrialized parts of the world, pointing to lifestyle and environmental forces that interact with biology in ways scientists are still untangling.
IBD is an umbrella term for two main conditions: Crohn’s disease and ulcerative colitis. Ulcerative colitis affects only the large intestine, starting in the rectum and spreading upward in a continuous line. Crohn’s disease can strike anywhere from the mouth to the anus and often skips sections, leaving patches of healthy tissue between inflamed areas. Crohn’s also reaches deeper into the intestinal wall. The causes overlap significantly, but some risk factors weigh more heavily for one type than the other.
Genetics Set the Stage
Your genes are the strongest known predictor of whether you’ll develop IBD, though they’re far from the whole story. Researchers have mapped 242 common genetic regions that increase susceptibility, and 45 of those have been narrowed down to specific causal variants. The first and most studied gene is NOD2, which plays a role in how your immune system detects bacteria. Certain mutations in NOD2 significantly raise the risk of Crohn’s disease specifically.
Other genes linked to IBD affect how your body processes inflammation, repairs the gut lining, or clears out damaged cells through a recycling process called autophagy. One well-known variant involves a gene that controls your immune system’s response to a specific inflammatory signal (IL-23), and another affects whether certain protective sugars coat the lining of your intestines. Having one or even several of these variants doesn’t guarantee you’ll develop IBD. Most people who carry risk genes never get the disease, which is why researchers focus heavily on what flips the switch.
An Immune System That Won’t Stand Down
In a healthy gut, immune cells constantly monitor the trillions of bacteria living in your intestines without overreacting. In IBD, that balance breaks down. The immune system treats normal gut bacteria as threats and launches an inflammatory response that never fully resolves.
The process typically starts with cells in the gut lining producing inflammatory signaling molecules in response to bacteria. In the early phase, these signals recruit waves of immune cells to the intestinal tissue. If the initial inflammation isn’t brought under control, a second, more aggressive wave of immune activity kicks in, driven by specialized immune cells that sustain chronic inflammation over weeks, months, and years.
Over time, this persistent inflammation can reshape the intestinal wall itself. The tissue may shift toward scarring and thickening, a process called fibrotic remodeling, which narrows the intestine and leads to some of the most serious complications of Crohn’s disease. This is why early and effective treatment matters so much: the longer inflammation goes unchecked, the harder it becomes to reverse structural damage.
Environmental Triggers and Lifestyle
Something in the modern environment is driving IBD rates upward, and researchers have identified several specific factors.
Smoking
Smoking has one of the strangest relationships with IBD of any risk factor. Both current and former smokers face a higher risk of developing Crohn’s disease, and smokers with Crohn’s tend to need more aggressive treatment, more surgeries, and experience more frequent flares. But in ulcerative colitis, the picture flips: current smokers tend to have a milder disease course and less need for surgery. People with ulcerative colitis who quit smoking frequently experience a relapse. Chronic smoke exposure changes immune responses, alters the gut microbiome, and disrupts the protective mucus layer lining the intestines, but exactly why these effects diverge between the two conditions remains unclear.
Diet
What you eat appears to influence IBD risk, though diet alone isn’t enough to cause or prevent the disease. Higher fiber intake from fruits and vegetables has been linked to a lower incidence of Crohn’s disease. Diets rich in omega-3 fatty acids (found in fish and some plant oils) are associated with lower ulcerative colitis risk, while diets heavy in omega-6 fatty acids (common in processed and fried foods) are linked to higher risk. High animal protein intake may also increase the likelihood of ulcerative colitis, while fish consumption may be protective.
Urbanization
IBD rates are climbing fastest in countries that are rapidly industrializing and urbanizing. In China, a study of over 3,400 IBD cases found that urban residents made up roughly 82% of diagnoses, with big-city dwellers accounting for nearly half of all cases compared to just 18% in rural areas. Research comparing gut bacteria between urban and rural populations in China found that city residents had a microbiome profile that looked more like that of Americans, who have much higher IBD rates. Crowding, air pollution, industrial waste, processed food availability, and work-related stress all appear to contribute.
The Gut Microbiome Connection
Your intestines are home to a vast community of bacteria, viruses, and fungi that help digest food, train your immune system, and maintain the gut barrier. People with IBD consistently show a less diverse microbiome than healthy individuals, with fewer beneficial species and sometimes an overgrowth of harmful ones. Urbanization, antibiotics, processed diets, and other aspects of modern life can all reduce microbial diversity.
This matters because gut bacteria are in constant communication with the immune system. Beneficial microbes stimulate the production of anti-inflammatory signals that keep the gut lining intact and prevent immune cells from overreacting. When this microbial community is disrupted, the immune system loses key regulatory inputs, and the balance tips toward inflammation. Whether microbiome changes cause IBD or result from it is still debated, but the evidence increasingly suggests both are true: an altered microbiome can initiate inflammation, and inflammation further disrupts the microbiome in a self-reinforcing cycle.
Common Painkillers Can Make Things Worse
Over-the-counter pain relievers like ibuprofen and naproxen (NSAIDs) are a recognized trigger for gut inflammation, which is particularly relevant for people with IBD or at risk for it. These drugs interfere with energy production inside cells lining the intestine, causing those cells to lose their tight connections with each other. The result is a leaky gut barrier that allows bacteria and other irritants to penetrate deeper into the intestinal wall. NSAIDs also reduce blood flow to the gut lining, and once the barrier is weakened, stomach acid, bile, and bacteria amplify the damage into full-blown erosions and ulcers. For people already living with IBD, NSAIDs are a well-known cause of disease flares.
Vitamin D and Immune Regulation
Low vitamin D levels are common in people with IBD, and there’s growing evidence that vitamin D does more than just reflect poor nutrient absorption from an inflamed gut. A Mayo Clinic study of 48 people with IBD found that vitamin D supplementation shifted their immune response in a protective direction: levels of an antibody associated with gut defense went up, while levels of one linked to inflammation went down. Disease activity scores and a stool-based inflammation marker also improved. The study was small and not designed to prove cause and effect, but it adds to a pattern suggesting that vitamin D plays an active role in regulating the immune system’s behavior in the gut rather than simply being depleted as a consequence of disease.
How These Factors Work Together
No single cause explains IBD. The current model is a chain of events: genetic susceptibility creates a vulnerability in how the immune system interacts with gut bacteria. Environmental exposures, whether diet, smoking, urban living, or medications, alter the microbiome or damage the gut barrier. The immune system responds with inflammation that, in a genetically predisposed person, escalates rather than resolving. Once that cycle starts, chronic inflammation sustains itself and can progressively damage the intestinal wall.
This is why IBD runs in families but doesn’t follow a simple inheritance pattern, why it’s more common in wealthy nations but rising fast in developing ones, and why two people with identical diagnoses can have very different disease courses. The causes are layered, and the specific combination differs from person to person. Current estimates place the number of Americans with IBD between 2.4 and 3.1 million, and that number continues to rise.